Loading...
Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma
BACKGROUND AND AIMS: Assessing treatment responses in hepatocellular carcinoma (HCC) is challenging, and alternative radiologic methods of measuring treatment response are required. Modified Response Evaluation Criteria in Solid Tumors (mRECIST) for HCC and alpha-fetoprotein (AFP) levels were assess...
Na minha lista:
| Udgivet i: | Liver Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger AG
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4531422/ https://ncbi.nlm.nih.gov/pubmed/26280005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000343872 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|